Cite this article:
Patel and Patel (2016). Cabapenem Resistance Among Non Fermenting Gram Negative Bacilli Isolated from Patients with Respiratory Infection in Critical Care Units. Journal of Ravishankar University (Part-B: Science), 29(1), pp.113.
PP-A01
Cabapenem
Resistance Among Non Fermenting Gram Negative Bacilli Isolated from Patients
with Respiratory Infection in Critical Care Units
Krishna Kumar Patel and Sarita
Patel
School of Studies in Chemistry.
Pt. Ravishankar Shukla University, Raipur 492010,
India National Center for Natural
Resources, Pr. Ravishankar Shukla University, Raipur -42010, India
Corresponding author email:
drkrishnabsp@ gmail.com
[Received
30 December 2015, accepted 29 January 2016]
Abstract: Carbapenems
are used for treating serious infections caused by multidrug resistant gram
negative bacilli including non-fermenters (NFGNB). Stability to B-lactamases
had made them the preferred drug of choice in infections with B-lactam-
resistant gram negative bacteria including non-fermenting bacteria (NFGNB). The
rapid dissemination of carbapenem is therapeutically challenging and
necessitates effective antibiotics policies and meticulous surveillance program
in a critical care setting. In a state like Chhattisgarh, where information on
microbiological aspects of various infectious diseases are negligible, present
study is an attempt to determine magnitude of carbapenem resistance in NFGNB
recovered from patients with respiratory tract infections in the intensive care
units Carbapenems have revolutionalised the treatment of potentially serious
infections caused by multidrug resistant gram negative bacilli. The study
confirms the occurrence of carbapenem resistance in NFGNB isolates recovered
from patients with respiratory infection in the intensive care units (ICUS) A
total of 676 endotracheal aspirate specimens were subjected to microbiological
work-up which yielded 358 NFGNB isolates in a study conducted at a teaching
hospital in tribal dominated region of Chhasttisgarh state during January 2015
to November 2015. A total of 48 NFGNB exhibited resistance to imipenem and
meropenem. The carbapenem resistance was predominant with Pseudomonas
aeruginosa (58.8 %). The enhanced status of NFGNB as nosocomial pathogens, simultancous
with their increased resistance to carbapenems is immensely worrisome and
threatens to disrupt-therapeutic approaches especially among those patients
admitted to critical care units.
Keywords: Carhapenem
resistance. NFGNB, ICU